Buy or sell Synthace stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Synthace Stock

Synthace is a Life Sciences R&D cloud platform that enables experiments to be automated, with the resultant data seamlessly integrated.

About Synthace Stock

Synthace is a R&D cloud platform. Synthace aims to automate experimentation and insight sharing for scientists to share, view, and access progress with cures and therapeutics in one place.

Synthace was founded in 2011 and is headquartered in London, White City. Notable investors include Horizons Ventures, Sofinnova Partners, Amadeus Capital Partners, and Luminous Ventures.

Funding History

August 2013$1.5M
January 2015$2.9M
September 2017$10.5M
June 2018$3.1M
December 2018$25.4M
November 2021$6.8M
November 2021$26.8M

Management

CEO

Guy Levy-Yurista

Co-founder & Chief Scientific Officer

Markus Gershater

Chief Product Officer

Mathieu Ayel

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 280K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo